EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

 

ASH 2019, Orlando – More than 25.000 attendees from more than 115 countries gather together in the 61st American Society of Hematology (ASH) Annual Congress. This is the largest world congress of hematology and will be held from today to 10 December 2019 in Orlando, Florida, USA.

There will be a number of myeloma updates. CAR-T, novel immunotherapies, drug combinations or the role of Minimal Residual Disease (MRD) will be some of the topics. Dr Katja Weisel, University Medical Center Hamburg-Eppendorf in Germany, spent some time with MPE to explain us the expected myeloma updates in the upcoming days.

 

 

 







Recent news

» EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myeloma

» EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.